Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Histiocytoses
ADR ID BADD_A02078
ADR Hierarchy
01      Blood and lymphatic system disorders
01.13      Haematopoietic neoplasms (excl leukaemias and lymphomas)
01.13.04      Histiocytoses
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.21      Haematopoietic neoplasms (excl leukaemias and lymphomas)
16.21.04      Histiocytoses
Description General term for the abnormal appearance of histiocytes in the blood. Based on the pathological features of the cells involved rather than on clinical findings, the histiocytic diseases are subdivided into three groups: HISTIOCYTOSIS, LANGERHANS CELL; HISTIOCYTOSIS, NON-LANGERHANS-CELL; and HISTIOCYTIC DISORDERS, MALIGNANT. [MeSH]
MedDRA Code 10020118
MeSH ID D015614
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Histiocytosis | Histiocytoses
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00356Carbamazepine0.000744%
BADD_D00405Ceftriaxone0.004457%
BADD_D00417Cetirizine0.000029%
BADD_D00474Cisplatin0.000168%
BADD_D00511Clozapine0.001834%
BADD_D00566Dabrafenib0.000448%
BADD_D00616Desmopressin0.001283%
BADD_D00858Everolimus--
BADD_D00932Fluoxetine--
BADD_D01136Imatinib0.000224%
BADD_D01243Lamotrigine0.000110%
BADD_D01295Linezolid0.006586%
BADD_D01496Montelukast0.000022%
BADD_D01564Nicotine0.000940%
BADD_D01662Pamidronic acid--
BADD_D01773Pimecrolimus--
BADD_D01831Prednisolone0.000052%
BADD_D01834Prednisone0.000022%
BADD_D02257Trametinib0.000336%
BADD_D02464Fingolimod0.000241%
The 1th Page    1    Total 1 Pages